カテゴリー： 世界, 医療/バイオ, Transparency Market Research

世界の遺伝子検査サービス市場2023-2031：検査種類別（出生前検査、新生児スクリーニング、予測・予兆検査、薬理ゲノム検査、その他）

【英語タイトル】Genetic Testing Services Market (Test Type: Prenatal Testing, New Born Screening, Predictive & Presymptomatic Testing, Pharmacogenomic Testing, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Transparency Market Researchが出版した調査資料（TMR23JUL216）・商品コード：TMR23JUL216
・発行会社（調査会社）：Transparency Market Research
・発行日：2023年5月
・ページ数：200
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Transparency Market Research社の市場調査では、世界の遺伝子検査サービス市場規模が2023年の150億ドルから2031年には315億ドルに達し、予想期間中の年平均成長率は8.4％を記録すると予想されています。本書では、遺伝子検査サービスの世界市場ついて広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要洞察、検査種類別（出生前検査、新生児スクリーニング、予測・予兆検査、薬理ゲノム検査、その他）分析、サービスプロバイダー別（病院研究室、診断研究室、専門診療所、その他）分析、用途別（がん、感染症、自己免疫疾患、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを整理しました。また、本書には、Laboratory Corporation of America Holdings、Quest Diagnostics Incorporated、Genomic Health, Inc.、NeoGenomics Laboratories, Inc.、Eurofins Scientific、Ambry Genetics、Illumina, Inc.、23andMe, Inc.などの企業情報が記載されています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・主要洞察
・世界の遺伝子検査サービス市場規模：検査種類別
- 出生前検査の市場規模
- 新生児スクリーニングの市場規模
- 予測・予兆検査の市場規模
- 薬理ゲノム検査の市場規模
- その他遺伝子検査サービスの市場規模
・世界の遺伝子検査サービス市場規模：サービスプロバイダー別
- 病院研究室における市場規模
- 診断研究室における市場規模
- 専門診療所における市場規模
- その他サービスプロバイダーにおける市場規模
・世界の遺伝子検査サービス市場規模：用途別
- がんにおける市場規模
- 感染症における市場規模
- 自己免疫疾患における市場規模
- その他用途における市場規模
・世界の遺伝子検査サービス市場規模：地域別
- 北米の遺伝子検査サービス市場規模
- ヨーロッパの遺伝子検査サービス市場規模
- アジア太平洋の遺伝子検査サービス市場規模
- 中南米の遺伝子検査サービス市場規模
- 中東・アフリカの遺伝子検査サービス市場規模
・競争状況

Genetic Testing Services Market – Scope of Report
TMR’s report on the global Genetic Testing Services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Genetic Testing Services market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Genetic Testing Services market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Genetic Testing Services market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Genetic Testing Services market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Genetic Testing Services market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Genetic Testing Services market.

The report delves into the competitive landscape of the global Genetic Testing Services market. Key players operating in the global Genetic Testing Services market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Genetic Testing Services market profiled in this report.

Key Questions Answered in Global Genetic Testing Services Market Report
• What is the sales/revenue generated by Genetic Testing Services across all regions during the forecast period?
• What are the opportunities in the global Genetic Testing Services market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Genetic Testing Services Market – Research Objectives and Research Approach
The comprehensive report on the global Genetic Testing Services market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Genetic Testing Services market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Genetic Testing Services market.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Genetic Testing Services Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
        4.1.2. Industry Evolution/Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Genetic Testing Services Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Mn)
        4.4.2. Market Volume/Unit Shipments Projections
    4.5. Porter’s Five Force Analysis
5. Key Insights
    5.1. Regulatory Scenario by Region/Globally
    5.2. Disease Prevalence & Incidence Rate Globally with Key Countries
    5.3. Technological Advancements
    5.4. COVID-19 Impact Analysis
6. Global Genetic Testing Services Market Analysis and Forecast, by Test Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Test Type, 2017 – 2031
        6.3.1. Prenatal Testing
        6.3.2. New Born Screening
        6.3.3. Predictive & Presymptomatic Testing
        6.3.4. Pharmacogenomic Testing
        6.3.5. Others
    6.4. Market Attractiveness Analysis, by Test Type
7. Global Genetic Testing Services Market Analysis and Forecast, by Service Provider
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Service Provider, 2017-2031
        7.3.1. Hospital-based Laboratories
        7.3.2. Diagnostic Laboratories
        7.3.3. Specialty Clinics
        7.3.4. Others
    7.4. Market Attractiveness Analysis, by Service Provider
8. Global Genetic Testing Services Market Analysis and Forecast, by Application
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Application, 2017-2031
        8.3.1. Oncology
        8.3.2. Infectious Diseases
        8.3.3. Autoimmune Diseases
        8.3.4. Others
    8.4. Market Attractiveness Analysis, by Application
9. Global Genetic Testing Services Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Genetic Testing Services Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Test Type, 2017-2031
        10.2.1. Prenatal Testing
        10.2.2. New Born Screening
        10.2.3. Predictive & Presymptomatic Testing
        10.2.4. Pharmacogenomic Testing
        10.2.5. Others
    10.3. Market Value Forecast, by Service Provider, 2017-2031
        10.3.1. Hospital-based Laboratories
        10.3.2. Diagnostic Laboratories
        10.3.3. Specialty Clinics
        10.3.4. Others
    10.4. Market Value Forecast, by Application, 2017-2031
        10.4.1. Oncology
        10.4.2. Infectious Diseases
        10.4.3. Autoimmune Diseases
        10.4.4. Others
    10.5. Market Value Forecast, by Country, 2017-2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Test Type
        10.6.2. By Service Provider
        10.6.3. By Application
        10.6.4. By Country
11. Europe Genetic Testing Services Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Test Type, 2017-2031
        11.2.1. Prenatal Testing
        11.2.2. New Born Screening
        11.2.3. Predictive & Presymptomatic Testing
        11.2.4. Pharmacogenomic Testing
        11.2.5. Others
    11.3. Market Value Forecast, by Service Provider, 2017-2031
        11.3.1. Hospital-based Laboratories
        11.3.2. Diagnostic Laboratories
        11.3.3. Specialty Clinics
        11.3.4. Others
    11.4. Market Value Forecast, by Application, 2017-2031
        11.4.1. Oncology
        11.4.2. Infectious Diseases
        11.4.3. Autoimmune Diseases
        11.4.4. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Spain
        11.5.5. Italy
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Test Type
        11.6.2. By Service Provider
        11.6.3. By Application
        11.6.4. By Country/Sub-region
12. Asia Pacific Genetic Testing Services Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Test Type, 2017-2031
        12.2.1. Prenatal Testing
        12.2.2. New Born Screening
        12.2.3. Predictive & Presymptomatic Testing
        12.2.4. Pharmacogenomic Testing
        12.2.5. Others
    12.3. Market Value Forecast, by Service Provider, 2017-2031
        12.3.1. Hospital-based Laboratories
        12.3.2. Diagnostic Laboratories
        12.3.3. Specialty Clinics
        12.3.4. Others
    12.4. Market Value Forecast, by Application, 2017-2031
        12.4.1. Oncology
        12.4.2. Infectious Diseases
        12.4.3. Autoimmune Diseases
        12.4.4. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Test Type
        12.6.2. By Service Provider
        12.6.3. By Application
        12.6.4. By Country/Sub-region
13. Latin America Genetic Testing Services Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Test Type, 2017-2031
        13.2.1. Prenatal Testing
        13.2.2. New Born Screening
        13.2.3. Predictive & Presymptomatic Testing
        13.2.4. Pharmacogenomic Testing
        13.2.5. Others
    13.3. Market Value Forecast, by Service Provider, 2017-2031
        13.3.1. Hospital-based Laboratories
        13.3.2. Diagnostic Laboratories
        13.3.3. Specialty Clinics
        13.3.4. Others
    13.4. Market Value Forecast, by Application, 2017-2031
        13.4.1. Oncology
        13.4.2. Infectious Diseases
        13.4.3. Autoimmune Diseases
        13.4.4. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Test Type
        13.6.2. By Service Provider
        13.6.3. By Application
        13.6.4. By Country/Sub-region
14. Middle East & Africa Genetic Testing Services Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Test Type, 2017-2031
        14.2.1. Prenatal Testing
        14.2.2. New Born Screening
        14.2.3. Predictive & Presymptomatic Testing
        14.2.4. Pharmacogenomic Testing
        14.2.5. Others
    14.3. Market Value Forecast, by Service Provider, 2017-2031
        14.3.1. Hospital-based Laboratories
        14.3.2. Diagnostic Laboratories
        14.3.3. Specialty Clinics
        14.3.4. Others
    14.4. Market Value Forecast, by Application, 2017-2031
        14.4.1. Oncology
        14.4.2. Infectious Diseases
        14.4.3. Autoimmune Diseases
        14.4.4. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Test Type
        14.6.2. By Service Provider
        14.6.3. By Application
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (by tier and size of companies)
    15.2. Market Share Analysis, by Company, 2022
    15.3. Company Profiles
        15.3.1. Laboratory Corporation of America Holdings
            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.1.2. Service Provider Portfolio
            15.3.1.3. Financial Overview
            15.3.1.4. SWOT Analysis
            15.3.1.5. Strategic Overview
        15.3.2. Quest Diagnostics Incorporated
            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.2.2. Service Provider Portfolio
            15.3.2.3. Financial Overview
            15.3.2.4. SWOT Analysis
            15.3.2.5. Strategic Overview
        15.3.3. Genomic Health, Inc.
            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.3.2. Service Provider Portfolio
            15.3.3.3. Financial Overview
            15.3.3.4. SWOT Analysis
            15.3.3.5. Strategic Overview
        15.3.4. NeoGenomics Laboratories, Inc.
            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.4.2. Service Provider Portfolio
            15.3.4.3. Financial Overview
            15.3.4.4. SWOT Analysis
            15.3.4.5. Strategic Overview
        15.3.5. Eurofins Scientific
            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.5.2. Service Provider Portfolio
            15.3.5.3. Financial Overview
            15.3.5.4. SWOT Analysis
            15.3.5.5. Strategic Overview
        15.3.6. Ambry Genetics
            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.6.2. Service Provider Portfolio
            15.3.6.3. Financial Overview
            15.3.6.4. SWOT Analysis
            15.3.6.5. Strategic Overview
        15.3.7. Illumina, Inc.
            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.7.2. Service Provider Portfolio
            15.3.7.3. Financial Overview
            15.3.7.4. SWOT Analysis
            15.3.7.5. Strategic Overview
        15.3.8. 23andMe, Inc.
            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.8.2. Service Provider Portfolio
            15.3.8.3. Financial Overview
            15.3.8.4. SWOT Analysis
            15.3.8.5. Strategic Overview

List of Tables

Table 01: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032

Table 02: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032

Table 03: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032

Table 04: Global Genetic Testing Services Market Value (US$ Mn) Forecast, by Region, 2017-2032

Table 05: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Country, 2017-2032

Table 06: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032

Table 07: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032

Table 08: North America Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032

Table 09: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032

Table 10: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032

Table 11: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032

Table 12: Europe Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032

Table 13: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032

Table 14: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032

Table 15: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032

Table 16: Asia Pacific Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032

Table 17: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032

Table 18: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032

Table 19: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032

Table 20: Latin America Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032

Table 21: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032

Table 22: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Test Type, 2017-2032

Table 23: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Service Provider, 2017-2032

Table 24: Middle East & Africa Genetic Testing Services Market Value (US$ Mn) Forecast, by Application, 2017-2032

★調査レポート[世界の遺伝子検査サービス市場2023-2031：検査種類別（出生前検査、新生児スクリーニング、予測・予兆検査、薬理ゲノム検査、その他）] (コード：TMR23JUL216)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の遺伝子検査サービス市場2023-2031：検査種類別（出生前検査、新生児スクリーニング、予測・予兆検査、薬理ゲノム検査、その他）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の遺伝子検査サービス市場2023-2033：検査タイプ別（出生前検査、新生児検診、予測＆予兆検査、ファーマコゲノム検査）、用途別（がん、感染症、自己免疫疾患）、サービスプロバイダー別（病院内ラボ、診断ラボ、専門クリニック）、地域別
  • 世界の遺伝子検査市場2023-2032年：種類別（予測・予兆検査、キャリア検査、出生前・新生児検査、診断検査、薬理ゲノム検査、その他）、技術別（細胞遺伝学的検査、生化学的検査、分子検査）、用途別（がん診断、遺伝病診断、その他）
  • 世界の新型コロナウイルス感染症用診断市場（2022-2031）：製品別（機器、試薬＆キット）、検査種類別（分子検査、抗原検査、抗体検査）
  • 世界のHIV/AIDS診断市場（2022-2031）：製品別（キット＆試薬、機器）、検査種類別（核酸検査、迅速検査、ELISA、その他）
  • 世界のHPV検査＆パップテスト市場2021-2031：検査種類別（HPV検査、パップテスト、同時検査）、用途別、検査場所別
  • 世界の尿路感染症検査市場2021-2031：感染種類別（尿道炎、膀胱炎、腎盂腎炎）、検査種類別（尿検査、尿培養、感受性試験）、エンドユーザー別（病院、診断研究所、研究機関）、検査キット別（家庭用検査キット、研究所用検査キット）
  • 世界の毒性薬物検査市場2023-2031：検査種類別（インビトロ、インビボ、インシリコ）、検査方法別（質量分析イメージング、電子顕微鏡、蛍光標識、免疫組織化学、その他）

    • ◆H&Iグローバルリサーチのお客様（例）◆